Loading clinical trials...
Loading clinical trials...
Randomized, Blinded Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and TNF-α Release
Conditions
Interventions
Mesna
Saline
+2 more
Locations
1
United States
University of Kentucky Markey Cancer Center
Lexington, Kentucky, United States
Start Date
September 1, 2010
Primary Completion Date
August 1, 2012
Completion Date
April 1, 2015
Last Updated
February 24, 2016
NCT05372640
NCT04704661
NCT04550494
NCT05245812
NCT05673200
NCT07483307
Lead Sponsor
Mara Chambers
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions